Acute home treatment of patients with hypoxemia due to respiratory infection in a regional network (HOME-ART study)
- Funded by Netherlands Organisation for Health Research and Development (ZonMW)
- Total publications:0 publications
Grant number: 10140302310006
Grant search
Key facts
Disease
COVID-19Start & end year
20242028Known Financial Commitments (USD)
$0Funder
Netherlands Organisation for Health Research and Development (ZonMW)Principal Investigator
MJM Breteler MScResearch Location
NetherlandsLead Research Institution
Universitair Medisch Centrum UtrechtResearch Priority Alignment
N/A
Research Category
Clinical characterisation and managementResearch Subcategory
Supportive care, processes of care and managementSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Not applicableBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified
Abstract
Home-based management of hypoxemic patients with acute respiratory tract infection in a care network (HOME-ART study) Acute respiratory tract infections (ALTI) cause a large burden of disease for patients every year. These patients are admitted to hospital. This regularly leads to a peak burden on hospital care. This study aims to demonstrate that acute treatment at home - rather than in hospital - is safe for patients with oxygen deficiency due to respiratory infections. This can also save hospital capacity and costs. Study and expected outcomes Patients may recover better at home and with more autonomy. In a previous study, a method was developed with which Covid-19 patients with oxygen deficiency were treated at home. This method for home treatment consists of 5 interrelated building blocks: a) medical care b) remote monitoring c) acute nursing home care d) equipment at home for, among other things, oxygen treatment e) care coordination Because this study is not only aimed at Covid-19 patients, but also at other types of acute respiratory infections that can be treated at home, the method is first made suitable for this. To this end, development is taking place of, among other things, 24/7-hour continuous monitoring and more options for antibiotic therapy. The patients will then be compared at home treatment with hospital admission, the outcome of which will be to determine whether acute home treatment is effective and as safe as hospital admission. Any cost savings are also calculated.